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agree completely that the mitral annulus
should be supported somehow, but our
experience suggests that suture annulo-
plasty gives good results without any
ring.
After our initial experience with suture
annuloplasty, published 8 years ago,2 we
performed several hundred mitral repairs
without annuloplasty rings and with good
early and midterm results. There are two
important factors in achieving a good
result with this method. The first is the
suture material. Both polypropylene
(Prolene; Ethicon, Inc, Somerville, NJ)
and polyester (Ethibond; Ethicon) sutures
were not reliable. Prolene was too elastic,
and in some cases the 3-0 Prolene thread
elongated, causing redilatation of the mi-
tral annulus. In a few cases, the Prolene
suture ruptured, causing recurrent mitral
regurgitation. Ethibond was difficult to
use in achieving proper and equal tensions
on the suture line and adequate shortening
of the annulus. We had superior ex-
periences with expanded polytetrafluoro-
ethylene (Gore-Tex; W. L. Gore &
Associates, Inc, Flagstaff, Ariz) sutures,
as also reported by others.3 The other im-
portant factor is that the sutures be placed
properly into the annulus. Neither sutures
in the left atrium in the vicinity of the an-
nulus nor sutures in the proximal parts of
the valve cusps give good results. This
should hold true even with ring annulo-
plasty.
Suture annuloplasty actually has advan-
tages relative to ring annuloplasty. Trans-
valvular gradient is significantly lower and
mitral valve area is significantly larger,
without differences in mitral regurgitation.4
The mitral annulus has a natural flexibility,
which results a 26% dilatation in diastole.5
The natural flexibility of the mitral annulus
is conserved with suture annuloplasty.
Suture annuloplasty is also a simpler and
much cheaper method of achieving stability
of the mitral annulus.
In our experience, if mitral repair is done,
mitral annuloplasty should be performed,
evenif theannulus isnot significantlydilated.
It is not absolutely necessary to use an annu-
loplasty ring, as Flameng and coworkers rec-
ommend1; suture annuloplasty can give
a good result as well. Their statement that
‘‘[N]onuse of annuloplasty ring is a risk fac-
tor for recurrent mitral valve regurgitation’’
would be true only if the comparison
included suture annuloplasty as well. We
have not compared suture annuloplasty
with annuloplasty rings, but in accordance
with our experience, we would recommend
the following conclusion instead: ‘‘Lack of
stabilization of the mitral annulus increases
the risk of recurrent mitral valve regurgita-
tion.’’
Istva´n Szentkira´lyi, MD
A´rpa´d Pe´terffy, MD, PhD
Zolta´n Galajda, MD, PhD
Department of Cardiac Surgery
Institution of Cardiology
University of Debrecen, Medical and Health
Science Centre
Debrecen, Hungary
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Reply to the Editor:
I thank Szentkira´lyi, Pe´terffy, and Galajda
for their interest in our study on the durabil-
ity of mitral valve repair in Barlow disease.
The point they try to make in their letter is
that mitral annuloplasty in myxoid mitral
valve degeneration does not necessarily
have to be a ring annuloplasty. This might
be correct; who knows?
The problem is that, nowadays, when
youmake a statement, hard data are required
to convince the medical and scientific com-
munity to agree with you. In our study on
the recurrence of mitral valve regurgitation
after successful repair of Barlow disease
and fibroelastic degeneration, we presented
and analyzed extensive preoperative, intrao-
perative, and postoperative data, including
long-term echocardiographic follow up. In
our study, patients received either a ring an-
nuloplasty or no annuloplasty at all. We did
not study any other form of annuloplasty,
and therefore it would not be correct to
draw such a general conclusion as, ‘‘Lack
of stabilization of the mitral annulus in-
creases the risk of recurrent mitral valve
regurgitation.’’ To advocate this statement,
one should test every possible form of
annuloplasty and compare them all with
no annuloplasty. In their own experience,
Szentkira´lyi, Pe´terffy, and Galajda mention
that some materials used for suture annulo-
plasty, such as polypropylene and polyester
sutures, cause recurrent regurgitation. Is
this not why the annuloplasty ring was
developed?
Before we conclude that ‘‘Lack of stabi-
lization of the mitral annulus increases the
risk of recurrent mitral valve regurgitation,’’
I invite Szentkira´lyi, Pe´terffy, and Galajda
to analyze their data on suture annuloplasty
in a scientific way and compare them with
results of repair procedures without annulo-
plasty, rather than relying on their own
experience, even with several hundred pa-
tients. I am well aware of the importance
of personal experiences of renowned sur-
geons such as our Hungarian colleagues,
and I appreciate the opportunity to share
these experiences. Before introducing a con-
cept into current praxis, however, I prefer
data-based, scientific proof.
W. Flameng, MD, PhD
Cardiac Surgery
Department of Cardiovascular Diseases
Katholieke Universiteit Leuven
Leuven, Belgium
doi:10.1016/j.jtcvs.2008.06.019
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Letters to the EditorQuestions on the angular
(Gothic) arch configuration and
its applicability after type I
aortic dissection repair
To the Editor:
I enjoyed the recent article ‘‘Angular
(Gothic) Aortic Arch Leads to Enhanced
Systolic Wave Reflection, Central Aortic
Stiffness, and Increased Left Ventricular
Mass Late After Aortic Coarctation Repair:
Evaluation With Magnetic Resonance Flow
Mapping,’’ by Ou and associates1 in a recent
issue of the Journal.1 Why were patientslar Surgery c Volume 136, Number 4 1103
Aprotinin and renal dysfunction:
The role of exposure to
angiotensin-converting enzyme
inhibitors
To the Editor:
I read with great interest the recent article by
Pagano and colleagues1 detailing their fa-
vorable experience with aprotinin in a large
patient series (N 5 7836: 1998–2006) from
a single institution. The authors demon-
strated that aprotinin exposure did not
significantly affect the incidence of postop-
erative renal dysfunction.
Careful review of this interesting paper re-
veals, however, that although hypertension
was significantly more common in the aproti-
nin cohort (63.3% vs 55.1%; P , .001), the
incidenceof exposure to angiotensin-convert-
ing enzyme (ACE) inhibitors is not indicated.
This is an important confounder, inasmuch as
ACE inhibitors in conjunction with aprotinin
have been shown to be associated with renal
dysfunction after cardiac surgery.2,3
As a consequence of this observation, I
have the following questions:
1. What was the incidence of ACE
inhibitor therapy in the aprotinin
cohort?
2. Was exposure to ACE inhibitors sig-
nificantly different in the aprotinin
cohort?
3. What was the percentage of off-pump
coronary bypass procedures, given
that aprotinin and ACE inhibitors
have recently been significantly asso-
ciated with postoperative renal dys-
function in this patient subgroup?3
4. Could the incidence ofACE inhibitor
exposure have confounded the re-
sults of the study, given the findings
from the literature?2,3 For example,
could a lack of renal toxicity from
aprotinin be explained by a low inci-
dence of exposure to ACE inhibitors
in the aprotinin cohort?
I congratulate the authors again on their
important contribution. I look forward to
their feedback about the impact of ACE
exposure and aprotinin on renal dysfunction
after cardiac surgery.
John G. T. Augoustides, MD, FASE
Associate Professor
Department of Anesthesiology and Critical Care
Hospital of the University of Pennsylvania
Philadelphia, PA 19104-4283
Financial support: Department of Anesthesiology
and Critical Care, Hospital of the University of
Pennsylvania.
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Reply to the Editor:
Dr Augoustides raises an appropriate point.
It is the policy in our unit to discontinue
angiotensin-converting enzyme inhibitors
or equivalents 24 hours before the operation
and for patients with impaired renal func-
tion, at least 48 hours before the operation.
However our database does not have infor-
mation on compliance to this policy. There-
fore, we could not address this issue in our
article.1
Domenico Pagano, MD, FRCS, FESC
Department of Cardiothoracic Surgery
University Hospital Birmingham
Edgbaston
Birmingham, West Midlands, United Kingdom
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Prosthetic valve thrombosis: A
regimen of treatment with low-
dose and longer-course using
recombinant tissue-type
plasminogen activator is
a promising protocol
To the Editor:
Despite the progress in anesthesia, cardiac
surgery, and perioperative care, the thera-
peutic decision in prosthetic valve thrombo-
sis (PVT) remains in discussion.
In recent years thrombolytic therapy has
won acceptance, and for many it is the first
Letters to the Editorwith bicuspid aortic valves excluded from
the study? Did patients with Gothic arches
and bicuspid valves have even greater
changes? Did any of the patients with
Gothic arch and a tricuspid aortic valve
have aortic insufficiency or require valve
replacement/repair?
Approximately 15% of patients who are
status-post repair of type I aortic dissection
require replacement of the proximal de-
scending aortic owing to increasing diame-
ter on long-term follow-up. It has also
been my impression that those patients
who have repair of type I aortic dissection
with replacement of the ascending aorta
and hemiarch repair have a greater incidence
of progressive aortic insufficiency and may
require aortic valve replacement or aortic
root replacement. This cohort is in contrast
to those patients with type I aortic dissection
who simply had ascending aortic replace-
ment and appeared to have a lesser inci-
dence of aortic insufficiency and valve or
root replacement over the long term.
Might the hemodynamic changes that
were documented in the pediatric angular
Gothic arch be present in this status-post
aortic dissection group and predispose to
aortic valve insufficiency and dilation of
the proximal portion of the distal descend-
ing thoracic aorta? Might this effect be
more pronounced in the hemiarch repair
that predisposes to an angular Gothic arch
configuration? Replacement of the ascend-
ing aorta only (without hemiarch repair)
usually preserves the concave configura-
tion of the ascending aorta and its gentle
curve into the transverse arch. Ascending
aorta and hemiarch replacement typically
has an angulated Gothic configuration
rather than the gentle curve that nature
favors.
Frank A. Baciewicz, Jr, MD
Professor of Cardiothoracic Surgery
Wayne State University
School of Medicine
Detroit, MI 48201
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